Cite
Medrano M, Arenaza L, Ramírez-Vélez R, et al. Prevalence of responders for hepatic fat, adiposity and liver enzyme levels in response to a lifestyle intervention in children with overweight/obesity: EFIGRO randomized controlled trial. Pediatr Diabetes. 2019;21(2):215-223doi: 10.1111/pedi.12949.
Medrano, M., Arenaza, L., Ramírez-Vélez, R., Ortega, F. B., Ruiz, J. R., & Labayen, I. (2020). Prevalence of responders for hepatic fat, adiposity and liver enzyme levels in response to a lifestyle intervention in children with overweight/obesity: EFIGRO randomized controlled trial. Pediatric diabetes, 21(2), 215-223. https://doi.org/10.1111/pedi.12949
Medrano, María, et al. "Prevalence of responders for hepatic fat, adiposity and liver enzyme levels in response to a lifestyle intervention in children with overweight/obesity: EFIGRO randomized controlled trial." Pediatric diabetes vol. 21,2 (2020): 215-223. doi: https://doi.org/10.1111/pedi.12949
Medrano M, Arenaza L, Ramírez-Vélez R, Ortega FB, Ruiz JR, Labayen I. Prevalence of responders for hepatic fat, adiposity and liver enzyme levels in response to a lifestyle intervention in children with overweight/obesity: EFIGRO randomized controlled trial. Pediatr Diabetes. 2020 Mar;21(2):215-223. doi: 10.1111/pedi.12949. Epub 2019 Dec 10. PMID: 31778277.
Copy
Download .nbib